Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalitis, Tick-Borne | 1 | 2019 | 41 | 0.620 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2019 | 47 | 0.610 |
Why?
|
| Meningoencephalitis | 1 | 2019 | 83 | 0.610 |
Why?
|
| Cross Infection | 1 | 2023 | 1422 | 0.450 |
Why?
|
| Occupational Exposure | 1 | 2023 | 1813 | 0.420 |
Why?
|
| HIV Infections | 17 | 2023 | 17337 | 0.350 |
Why?
|
| Health Personnel | 1 | 2023 | 3333 | 0.330 |
Why?
|
| Monkeypox virus | 2 | 2022 | 43 | 0.250 |
Why?
|
| Anti-HIV Agents | 7 | 2015 | 4524 | 0.240 |
Why?
|
| Post-Exposure Prophylaxis | 2 | 2015 | 110 | 0.220 |
Why?
|
| Needlestick Injuries | 1 | 2023 | 71 | 0.210 |
Why?
|
| Gloves, Protective | 1 | 2001 | 23 | 0.200 |
Why?
|
| HIV Protease Inhibitors | 2 | 2001 | 432 | 0.190 |
Why?
|
| HIV Protease | 1 | 2001 | 97 | 0.190 |
Why?
|
| Stethoscopes | 1 | 2001 | 30 | 0.190 |
Why?
|
| Protective Clothing | 1 | 2001 | 103 | 0.190 |
Why?
|
| Anthozoa | 1 | 2021 | 65 | 0.190 |
Why?
|
| Sequence Analysis | 1 | 2021 | 240 | 0.190 |
Why?
|
| Vancomycin Resistance | 1 | 2001 | 125 | 0.180 |
Why?
|
| Enterococcus | 1 | 2001 | 159 | 0.170 |
Why?
|
| Equipment Contamination | 1 | 2001 | 182 | 0.170 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 2 | 2012 | 61 | 0.170 |
Why?
|
| Patient Isolation | 1 | 2020 | 100 | 0.170 |
Why?
|
| Drug Resistance, Microbial | 1 | 2001 | 825 | 0.160 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2012 | 662 | 0.150 |
Why?
|
| Latent Tuberculosis | 1 | 2021 | 224 | 0.150 |
Why?
|
| Health Facilities | 1 | 2023 | 578 | 0.150 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2023 | 391 | 0.150 |
Why?
|
| DNA Primers | 1 | 2021 | 2817 | 0.140 |
Why?
|
| Disease Outbreaks | 2 | 2023 | 1748 | 0.140 |
Why?
|
| Hydroxyurea | 1 | 1998 | 282 | 0.140 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 5835 | 0.120 |
Why?
|
| Immunoglobulin M | 1 | 2019 | 1526 | 0.110 |
Why?
|
| Ambulatory Care | 2 | 2015 | 2768 | 0.110 |
Why?
|
| Lyme Disease | 1 | 2019 | 631 | 0.110 |
Why?
|
| Emergency Medical Services | 2 | 2015 | 1921 | 0.110 |
Why?
|
| HIV-1 | 3 | 2010 | 6858 | 0.100 |
Why?
|
| Lung Diseases | 2 | 2012 | 1909 | 0.100 |
Why?
|
| Brain | 1 | 2019 | 27101 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2001 | 1977 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 6 | 2012 | 2567 | 0.100 |
Why?
|
| Orthomyxoviridae | 1 | 2012 | 149 | 0.090 |
Why?
|
| Fever | 1 | 2019 | 1618 | 0.090 |
Why?
|
| Headache | 1 | 2019 | 1255 | 0.090 |
Why?
|
| Viral Load | 6 | 2012 | 3325 | 0.090 |
Why?
|
| Lymphatic Diseases | 1 | 2012 | 320 | 0.090 |
Why?
|
| Genes, MHC Class I | 1 | 2010 | 235 | 0.090 |
Why?
|
| Brain Diseases | 1 | 2019 | 1545 | 0.080 |
Why?
|
| HLA-B Antigens | 1 | 2010 | 317 | 0.080 |
Why?
|
| Respiratory System | 1 | 2012 | 563 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2021 | 330 | 0.080 |
Why?
|
| Community-Acquired Infections | 1 | 2012 | 469 | 0.080 |
Why?
|
| Hepatitis C | 2 | 2009 | 1579 | 0.070 |
Why?
|
| Humans | 31 | 2023 | 760617 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 12966 | 0.070 |
Why?
|
| Liver Cirrhosis | 3 | 2023 | 1926 | 0.070 |
Why?
|
| Benzoxazines | 1 | 2008 | 316 | 0.070 |
Why?
|
| Migraine Disorders | 1 | 2019 | 1701 | 0.070 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2008 | 172 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 753 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2010 | 1250 | 0.060 |
Why?
|
| HIV | 3 | 2023 | 1579 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5332 | 0.060 |
Why?
|
| Interferons | 1 | 2007 | 703 | 0.060 |
Why?
|
| Drug Resistance, Viral | 1 | 2009 | 861 | 0.060 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2012 | 1167 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
| Status Epilepticus | 1 | 2008 | 460 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2014 | 2174 | 0.050 |
Why?
|
| Massachusetts | 3 | 2022 | 8833 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2009 | 1330 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2023 | 23972 | 0.050 |
Why?
|
| RNA, Viral | 3 | 2021 | 2838 | 0.050 |
Why?
|
| Influenza, Human | 1 | 2012 | 1518 | 0.050 |
Why?
|
| Furans | 1 | 2001 | 202 | 0.040 |
Why?
|
| Academic Medical Centers | 2 | 2020 | 2756 | 0.040 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2000 | 76 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2022 | 270 | 0.040 |
Why?
|
| Carbamates | 1 | 2001 | 191 | 0.040 |
Why?
|
| HIV Wasting Syndrome | 1 | 2000 | 99 | 0.040 |
Why?
|
| Risk | 1 | 2012 | 9604 | 0.040 |
Why?
|
| Ticks | 1 | 2019 | 70 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2008 | 1894 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2007 | 1297 | 0.040 |
Why?
|
| Quality Control | 1 | 2021 | 831 | 0.040 |
Why?
|
| Stavudine | 1 | 1998 | 85 | 0.040 |
Why?
|
| Didanosine | 1 | 1998 | 151 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2021 | 665 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 548 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2006 | 2197 | 0.040 |
Why?
|
| Species Specificity | 1 | 2001 | 2411 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2001 | 1739 | 0.040 |
Why?
|
| Workflow | 1 | 2021 | 849 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2015 | 6305 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2045 | 0.030 |
Why?
|
| Radiography, Thoracic | 2 | 2012 | 1302 | 0.030 |
Why?
|
| Insect Proteins | 1 | 1996 | 254 | 0.030 |
Why?
|
| Cohort Studies | 5 | 2020 | 41457 | 0.030 |
Why?
|
| Female | 12 | 2023 | 392148 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2001 | 1936 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1998 | 621 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 2000 | 750 | 0.030 |
Why?
|
| Boston | 2 | 2020 | 9313 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 846 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2713 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2019 | 1070 | 0.030 |
Why?
|
| Diarrhea | 1 | 2019 | 1317 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2000 | 1201 | 0.020 |
Why?
|
| Liver | 2 | 2023 | 7512 | 0.020 |
Why?
|
| Aged | 3 | 2020 | 169042 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 36402 | 0.020 |
Why?
|
| Adult | 9 | 2020 | 220969 | 0.020 |
Why?
|
| Male | 11 | 2020 | 360358 | 0.020 |
Why?
|
| DNA Replication | 1 | 1998 | 1414 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2020 | 1935 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2010 | 140 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
| HIV Long-Term Survivors | 1 | 2010 | 121 | 0.020 |
Why?
|
| HIV Antigens | 1 | 2010 | 325 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2000 | 1662 | 0.020 |
Why?
|
| Reminder Systems | 1 | 2012 | 386 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2021 | 9643 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 1998 | 1529 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2012 | 442 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1996 | 1698 | 0.020 |
Why?
|
| Alkynes | 1 | 2008 | 320 | 0.020 |
Why?
|
| Transaminases | 1 | 2007 | 199 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2008 | 432 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2012 | 934 | 0.020 |
Why?
|
| Health Services Research | 1 | 2014 | 1808 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2008 | 436 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1998 | 2329 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15498 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2023 | 80566 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10505 | 0.020 |
Why?
|
| Ribavirin | 1 | 2007 | 392 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 5424 | 0.020 |
Why?
|
| Amino Acids | 1 | 2010 | 1717 | 0.010 |
Why?
|
| Haplotypes | 1 | 2010 | 2713 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1996 | 4512 | 0.010 |
Why?
|
| United States | 2 | 2022 | 72272 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 20074 | 0.010 |
Why?
|
| Necrosis | 1 | 2007 | 1610 | 0.010 |
Why?
|
| Young Adult | 3 | 2015 | 59179 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 7402 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2010 | 3965 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6474 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1998 | 7995 | 0.010 |
Why?
|
| Mutation | 2 | 2009 | 30016 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 26049 | 0.010 |
Why?
|
| Middle Aged | 4 | 2020 | 220584 | 0.010 |
Why?
|
| Phylogeny | 1 | 2009 | 2806 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 13347 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1998 | 10199 | 0.010 |
Why?
|
| Virus Replication | 1 | 2009 | 2427 | 0.010 |
Why?
|
| Hospitalization | 1 | 2020 | 10704 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8645 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2010 | 5433 | 0.010 |
Why?
|
| Animals | 3 | 2021 | 168201 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1996 | 7847 | 0.010 |
Why?
|
| Alleles | 1 | 2010 | 6861 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 39913 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 20556 | 0.010 |
Why?
|
| Cefotaxime | 1 | 1998 | 35 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2010 | 3045 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12758 | 0.010 |
Why?
|
| Bile | 1 | 1998 | 298 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1998 | 510 | 0.010 |
Why?
|
| Cephalosporins | 1 | 1998 | 198 | 0.010 |
Why?
|
| Peritoneum | 1 | 1998 | 225 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2012 | 9311 | 0.010 |
Why?
|
| Amoxicillin | 1 | 1998 | 180 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 4571 | 0.010 |
Why?
|
| Wnt1 Protein | 1 | 1996 | 121 | 0.010 |
Why?
|
| Genes, Insect | 1 | 1996 | 264 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2014 | 54360 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13245 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1996 | 767 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 6762 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 7237 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2007 | 3039 | 0.010 |
Why?
|
| Penicillins | 1 | 1998 | 402 | 0.010 |
Why?
|
| Solubility | 1 | 1996 | 1089 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13495 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74115 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1996 | 2178 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 1996 | 768 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2006 | 12447 | 0.010 |
Why?
|
| Extremities | 1 | 1996 | 867 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12661 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 15908 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1996 | 1132 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 36152 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 42188 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 14591 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 1971 | 0.000 |
Why?
|
| Drosophila melanogaster | 1 | 1996 | 1712 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 58894 | 0.000 |
Why?
|
| Bacteria | 1 | 1998 | 2192 | 0.000 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1996 | 3608 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 13441 | 0.000 |
Why?
|
| Child | 1 | 2012 | 80079 | 0.000 |
Why?
|
| Adolescent | 1 | 2012 | 88234 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 17629 | 0.000 |
Why?
|
| Proteins | 1 | 1996 | 6030 | 0.000 |
Why?
|
Concepts
(206)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(88)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_